Major advances in bipolar disorder

Medical Journal of Australia

Volumn 181, Issue 4, 2004, Pages 207-210

  Mitchell, Philip B ^a,b   Malhi, Gin S ^a,b   Ball, Jillian R ^a,b  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b PRINCE OF WALES HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; ARIPIPRAZOLE; ATYPICAL ANTIPSYCHOTIC AGENT; CARBAMAZEPINE; FLUOXETINE; LAMOTRIGINE; LITHIUM; OLANZAPINE; QUETIAPINE; RISPERIDONE; SEROTONIN UPTAKE INHIBITOR; TRANQUILIZER; VALPROIC ACID;

ANXIETY DISORDER; ARTICLE; BEHAVIOR THERAPY; BIPOLAR DEPRESSION; BIPOLAR DISORDER; BIPOLAR MANIA; BODY WEIGHT DISORDER; BRAIN RADIOGRAPHY; CLINICAL TRIAL; COGNITIVE THERAPY; COMORBIDITY; CONVALESCENCE; DIABETES MELLITUS; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISABILITY; DRUG ERUPTION; EPIDEMIOLOGICAL DATA; FUNCTIONAL ASSESSMENT; GENETIC SCREENING; HUMAN; HYPERLIPIDEMIA; LONG TERM CARE; MANIA; MIXED MANIA AND DEPRESSION; MOOD DISORDER; NEUROPATHOLOGY; RAPID CYCLING BIPOLAR DISORDER; STEVENS JOHNSON SYNDROME; SUBSTANCE ABUSE; SUICIDE; SYMPTOMATOLOGY; TREATMENT PLANNING;

EID: 4444351848     PISSN: 0025729X     EISSN: None     Source Type: Journal    
DOI: 10.5694/j.1326-5377.2004.tb06238.x     Document Type: Article

References (44)

1. Hawley J. Sink or swim. Sydney Morning Herald 2004 Jan 31; Good Weekend Suppl: 18-21.
2. Access Economics and SANE Australia. Bipolar disorder: costs. An analysis of the burden of bipolar disorder and related suicide in Australia. Melbourne: SANE Australia, 2003.
3. Hirschfeld RM, Lewis L, Vornik LA. Perceptions and impact of bipolar disorder: how far have we really come? Results of the National Depressive And Manic-Depressive Association 2000 survey of individuals with bipolar disorder. J Clin Psychiatry 2003; 64: 161-174.
4. Mitchell PB, Slade T, Andrews G. Twelve-month prevalence and disability of DSM-IV bipolar disorder in an Australian general population survey. Psychol Med 2004; 34: 777-785.
5. Angst J, Gamma A, Benazzi F, et al. Toward a re-definition of subthreshold bipolarity: epidemiology and proposed criteria for bipolar-II, minor bipolar disorders and hypomania. J Affect Disord 2003; 73: 133-146.
6. Malhi GS, Mitchell P, Salim S. Bipolar depression: management options. CNS Drugs 2003; 17: 9-25.
7. Mitchell P, Wilhelm K, Parker G, et al. The clinical features of bipolar depression: a comparison with matched major depressive disorder patients. J Clin Psychiatry 2001; 62: 212-216.
8. Judd LL, Akiskal HS, Schettler PJ, et al. The long-term natural history of the weekly symptomatic status of bipolar I disorder. Arch Gen Psychiatry 2002; 59: 530-537.
9. Judd LL, Akiskal HS, Schettler PJ, et al. A prospective investigation of the natural history of the long-term weekly symptomatic status of bipolar II disorder. Arch Gen Psychiatry 2003; 60: 261-269.
10. Harris EC, Barraclough B. Suicide as an outcome for mental disorders. Br J Psychiatry 1997; 170: 205-228.
11. Mitchell PB, Malhi GS. Bipolar depression: phenomenological overview and clinical characteristics. Bipolar Disord 2004. In press.
12. Angst F, Stassen HH, Clayton PJ, Angst J. Mortality of patients with mood disorders: follow-up over 34-38 years. J Affect Disord 2002; 68: 167-181.
13. Kessler RC. The epidemiology of DSM-III-R bipolar I disorder in a general population survey. Psychol Med 1997; 27: 1079-1089.
14. Bauer MS, Kirk FG, Gavin C, Williford WO. Determinants of functional outcome and healthcare costs in bipolar disorder: a high-intensity follow-up study. J Affect Disord 2001; 65: 231-241.
15. Bryant-Comstock L, Stender M, Devercelli G. Health care utilization and costs among privately insured patients with bipolar I disorder. Bipolar Disord 2002; 6: 398-405.
16. Altshuler LL, Gitlin MJ, Mintz J, et al. Subsyndromal depression is associated with functional impairment in patients with bipolar disorder. J Clin Psychiatry 2002; 63: 807-811.
17. McGuffin P, Rijsdijk F, Andrew M, et al. The heritability of bipolar affective disorder and the genetic relationship to unipolar depression. Arch Gen Psychiatry 2003; 60: 497-502.
18. Mortensen PB, Pedersen CB, Melbye M, et al. Individual and familial risk factors for bipolar affective disorders in Denmark. Arch Gen Psychiatry 2003; 60: 1209-1215.
19. Segurado R, Detera-Wadleigh SD, Levinson DF, et al. Genome scan meta-analysis of schizophrenia and bipolar disorder. Part III: bipolar disorder. Am J Hum Genet 2003; 73: 49-62.
20. Levinson DF, Levinson MD, Segurado R, Lewis CM. Genome scan meta-analysis of schizophrenia and bipolar disorder, part I: methods and power analysis. Am J Hum Genet 2003; 73: 17-33.
21. Pilcher HR. Drug research: the ups and downs of lithium. Nature 2003; 425: 118-120.
22. Soares JC. Contributions from brain imaging to the elucidation of pathophysiology of bipolar disorder. Int J Neuropsychopharmacol 2003; 6: 171-180.
23. Malhi GS, Lagopoulos J, Sachdev P, et al. Cognitive generation of affect in hypomania: an fMRI study. Bipolar Disord 2004. In press.
24. Malhi GS, Lagopoulos J, Ward P, et al. Cognitive generation of affect in bipolar depression: an fMRI study. Eur J Neurosci 2004; 19: 741-754.
25. Mitchell P, Parker G. Treatment of bipolar disorder. Med J Aust 1991; 155: 488-493.
26. Royal Australian and New Zealand College of Psychiatrists Clinical Practice Guidelines Team for Bipolar Disorder. Australian and New Zealand clinical practice guidelines for the treatment of bipolar disorder. Aust N Z J Psychiatry 2004; 38: 280-305.
27. National Health and Medical Research Council. How to use the evidence: assessment and application of scientific evidence. Table 1.3: designation of levels of evidence. Feb 2000. Available at: www.health.gov.au/nhmrc/publications/pdf/cp69.pdf (accessed Jun 2004).
28. Macritchie K, Geddes JR, Scott J, et al. Valproate for acute mood episodes in bipolar disorder. Cochrane Database Syst Rev 2003; 1: CD004052.
29. Rendell JM, Gijsman HJ, Keck P, et al. Olanzapine alone or in combination for acute mania. Cochrane Database Syst Rev 2003; 3: CD004040.
30. Mitchell PB, Hadzi-Pavlovic D. John Cade and the discovery of lithium treatment for manic depressive illness. Med J Aust 1999; 171: 262-264.
31. Poolsup N, Li Wan Po A, de Oliveira IR. Systematic overview of lithium treatment in acute mania. J Clin Pharm Ther 2000; 25: 139-156.
32. Swann AC, Bowden CL, Morris D, et al. Depression during mania. Treatment response to lithium or divalproex. Arch Gen Psychiatry 1997; 54: 37-42.
33. Calabrese JR, Bowden CL, Sachs GS, et al. A double-blind placebo-controlled study of lamotrigine monotherapy in outpatients with bipolar I depression. Lamictal 602 Study Group. J Clin Psychiatry 1999; 60: 79-88.
34. Bowden CL, Calabrese JR, Sachs G, et al. A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently manic or hypomanic patients with bipolar I disorder. Arch Gen Psychiatry 2003; 60: 392-400.
35. Calabrese JR, Bowden CL, Sachs G. A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently depressed patients with bipolar disorder. J Clin Psychiatry 2003; 64: 1013-1024.
36. Goldsmith DR, Wagstaff AJ, Ibbotson T, Perry CM. Lamotrigine: a review of its use in bipolar disorder. Drugs 2003; 63: 2029-2050.
37. Tohen M, Vieta E, Calabrese J, et al. Efficacy of olanzapine and olanzapine-fluoxetine combination in the treatment of bipolar I depression. Arch Gen Psychiatry 2003; 60: 1079-1088.
38. Burgess S, Geddes J, Hawton K, et al. Lithium for maintenance treatment of mood disorders. Cochrane Database Syst Rev 2002; 3: CD003013.
39. Goodwin FK, Fireman B, Simon GE, et al. Suicide risk in bipolar disorder during treatment with lithium and divalproex. JAMA 2003; 290: 1467-1473.
40. Manji HK, Moore GJ, Rafkowska G, et al. Neuroplasticity and cellular resilience in mood disorders. Mol Psychiatry 2000; 5: 578-593.
41. Tohen M, Ketter TA, Zarate CA, et al. Olanzapine versus divalproex sodium for the treatment of acute mania and maintenance of remission: a 47-week study. Am J Psychiatry 2003; 160: 1263-1271.
42. Lam DH, Watkins ER, Hayward P. A randomised controlled study of cognitive therapy for relapse prevention for bipolar affective disorder: outcome of the first year. Arch Gen Psychiatry 2003; 60: 145-152.
43. Perry A, Tarrier N, Morriss R, et al. Randomised controlled trial of efficacy of teaching patients with bipolar disorder to identify early symptoms of relapse and obtain treatment. BMJ 1999; 318: 149-153.
44. Frank E, Kupfer DJ, Ihlers CL, et al. Interpersonal and social rhythm therapy for bipolar disorder. Behav Ther 1994; 17: 143-149.